GlassScriptPhysician profile
Libby A Combs
NPI 1386400471
$1,078.05
in general payments reported to CMS, 2019-2025
11 companies · $551 in 2025
The $551 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $527 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $552.67 | 2024-2025 | Annovera |
| Sage Therapeutics, LLC | $117.58 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $92.98 | 2024-2025 | Veozah |
| Organon LLC | $91.83 | 2024 | |
| Sumitomo Pharma America, INC. | $61.48 | 2024-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $44.12 | 2024 | |
| Pfizer INC. | $41.37 | 2024 | |
| Baxter Healthcare | $26.51 | 2025 | Perclot |
| Abbvie INC. | $19.87 | 2024 | |
| Lilly USA, LLC | $16.00 | 2025 | Zepbound |
| Hologic Sales and Service, LLC | $13.64 | 2025 | Thinprep 2000 Processor, Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Libby Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.